This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Ge Healthcare Limited. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2022
Title: Innovations of Thanushan Rajanayagam
Introduction
Thanushan Rajanayagam is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of radiofluorination reactions, particularly in the development of methods and formulations that enhance the preparation of PET tracers. With a total of 3 patents to his name, Rajanayagam continues to push the boundaries of innovation in his field.
Latest Patents
One of his latest patents focuses on a novel method for the preparation of F-fluoride (18F) for use in radiofluorination reactions. This method is particularly advantageous for the preparation of 18F-labelled PET tracers, especially when bulk solutions are stored in prefilled vials. Additionally, he has developed a composition comprising anti-1-amino-3-F-fluorocyclobutyl-1-carboxylic acid (F-FACBC), which boasts an improved impurity profile compared to previous compositions.
Career Highlights
Thanushan Rajanayagam is currently employed at GE Healthcare Limited, where he applies his expertise in the development of innovative solutions for medical imaging. His work has been instrumental in advancing the capabilities of PET technology, which plays a crucial role in modern diagnostics.
Collaborations
Throughout his career, Rajanayagam has collaborated with esteemed colleagues such as Knut Richard Dyrstad and Torild Wickstrom. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking advancements in the field.
Conclusion
Thanushan Rajanayagam's contributions to the field of radiofluorination and PET technology exemplify the impact of innovative thinking in healthcare. His ongoing work continues to pave the way for advancements that improve diagnostic capabilities and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile